Form N-CEN - Annual Report for Registered Investment Companies:
SEC Accession No. 0001410368-25-033736
Filing Date
2025-12-08
Accepted
2025-12-08 14:56:49
Documents
3
Period of Report
2025-09-30
Effectiveness Date
2025-12-08

Document Format Files

Seq Description Document Type Size
1 primary_doc.html N-CEN  
1 primary_doc.xml N-CEN 27117
2 NCEN_811-06565_34537336_0925.htm INTERNAL CONTROL RPT 7257
3 NCEN_811-06565_67826429_0925.htm MATERIAL AMENDMENTS 13386
  Complete submission text file 0001410368-25-033736.txt   49085
Mailing Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103
Business Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103 6177728515
abrdn Life Sciences Investors (Filer) CIK: 0000884121 (see all company filings)

EIN.: 043147016 | State of Incorp.: MA | Fiscal Year End: 0930
Type: N-CEN | Act: 40 | File No.: 811-06565 | Film No.: 251555783